SCREENING STUDY OF NEUROTROPIC PROPERTIES OF NEW TRIAZOLE DERIVATIVE
S.D. Rakhimboev , Basic doctoral student Institute of Plant Chemistry named after S.Yu. Yunusov of the Academy of Sciences of the Republic of Uzbekistan Tashkent, Uzbekistan Z.I. Sanoev , PhD, Senior Researcher S.Yu. Yunusov Institute of Plant Chemistry of the Academy of Sciences of the Republic of Uzbekistan Tashkent, Uzbekistan T.T. Khamroev , Basic doctoral student Institute of Plant Chemistry named after S.Yu. Yunusov of the Academy of Sciences of the Republic of Uzbekistan Tashkent, Uzbekistan S.Z. Rashidov , Junior Researcher S.Y. Yunusov Institute of Plant Chemistry of the Academy of Sciences of the Republic of Uzbekistan Tashkent, Uzbekistan I.T. Abdinazarov , Basic doctoral student Institute of Plant Chemistry named after S.Yu. Yunusov of the Academy of Sciences of the Republic of Uzbekistan Tashkent, Uzbekistan D.S. Ismailova , PhD, Senior Researcher S.Yu. Yunusov Institute of Plant Chemistry of the Academy of Sciences of the Republic of Uzbekistan Tashkent, Uzbekistan B.J. Elmuradov , Doctor of Chemical Sciences, professor S.Yu. Yunusov Institute of Plant Chemistry of the Academy of Sciences of the Republic of Uzbekistan Tashkent, UzbekistanAbstract
In this article, as a continuation of scientific research on the study of the neurological activity of newly synthesized compounds, the results of studies of the neutropic activity of the 1,2,4 triazole derivative are presented. At the same time, the motor and search activity of compound D-378 was studied in the study conditions, the effect on M-cholinergic receptors in the arecoline tremor method, the effect on catalepsy with haloperidol, and anxiolytic activity. Studies have shown that the compound D-378 exhibits m-cholinomimetic and anxiolytic activity, and also increases the motor and search activity of animals without affecting the catalepsin of gloperidol. This, in turn, requires extensive scientific studies of other neurological activities of the D-378 compound.
Keywords
arecoline tremor, motor activity, research activity
References
Khamroev T.T., Sanoev Z.I., Rakhimboev S.D., Abdinazarov I.T., Rashidov S.Z. Effect of antiarrhythmic substance N – dezacetyllapoconitin on the central nervous system. ISJ Theoretical &Applied Science, 07 (99), 153-157. http://soi.org/1.1/TAS-07-99-31 Doi:https://dx.doi.org/10.15863
Sanoev Zafar Isomiddinovich, Rashidov Sokhib Zamon ugli, Raximboev Sukhrob Davlatyor ugli, Abdinazarov Ibrokhim Tuychievich, Khamroev Tolmas Tolibovich, Ismailova Dilnoza Safaralievna, & Elmuradov Burkhon Juraevich. (2022). Research of Anticonvulsant Activity of Compound 5- (P-Aminophenyl) - 1,3,4-Oxadiazole-2-Thion. Texas Journal of Medical Science, 13, 17–21. Retrieved from https://zienjournals.com/index.php/tjms/article/view/2434
Саноев З.И., Ҳамроев Т.Т., Абдиназаров И.Т., Садиков А.З., Рахимбоев С.Д., Рашидов С.З. N–дезацетиллаппаконитин (N- ДАЛ) нинг тутқаноққа қарши фаоллигини ўрганиш. Oriental journal of medicine and pharmacology. Pages: ISSN: 2181-2799 Year 2022 29-37 DOI: https://doi.org/10.37547/supsci-ojmp-02-02-04.
Rashidov S.Z., Rakhimboev S.D., Sanoev Z.I., Abdinazarov I.T., Khamroev T.T., Ismailova D.S., & Elmuradov B.J.. (2022). Study of psychoactive activity potassium salt 5-(o-aminophenyl)-1,3,4- oxadiazole-2-thion (D-361). International Journal of Medical Sciences And Clinical Research, 2(09), 1–5. https://doi.org/10.37547/ijmscr/Volume02Issue09-01
S.D. Rakhimboev, Z.I. Sanoev and others. Screening Study of the Anxiolytic Activity of New Triazole Compounds. Texas Journal of Medical Science. ISSN NO: 2770-2936. Vol. 13. p.1-4. 2022.
X.Q. Deng, L.N. Quan, M.X. Song, C.X. Wei, Z.S. Quan, Zhe-Shan Quan, Synthesis and anticonvulsant activity of 7-phenyl-6,7-dihydro-[1,2,4] triazolo [1,5-a] pyrimidin-5(4H)-ones and their derivatives, Eur. J. Med. Chem. 46 (2011) 2955-2963.
R. Aggarwal, G. Sumran, An insight on medicinal attributes of 1,2,4-triazoles, European Journal of Medicinal Chemistry, https://doi.org/10.1016/j.ejmech.2020.112652.
Миронов А.Н. и др. Руководство по проведению доклинических исследований лекарственных средств. Т-1. М.: Гриф и К, 2012. — 944 с.
Хабриев Р.У. Руководство по экспериментальному (доклиническому) изучению новых фармакологических веществ. с-775. «Медицина» М. 2005.
Стрелков Р.Б. Статистические таблицы для ускоренной количественной оценки фармакологического эффекта. Фармакология и токсикология 1986. №4 с.100-104.
Article Statistics
Copyright License
Copyright (c) 2022 S.D. Rakhimboev, Z.I. Sanoev, T.T. Khamroev, S.Z. Rashidov , I.T. Abdinazarov, D.S. Ismailova, B.J. Elmuradov
This work is licensed under a Creative Commons Attribution 4.0 International License.